Cerbios offers customized high-performance stable mammalian cell line development for manufacturing of monoclonal antibodies and recombinant proteins.
Cerbios is setting up a platform for the generation of high-producer stable CHO cell lines for the expression of monoclonal antibodies and recombinant proteins.
Starting from the gene sequence, Cerbios provides services of optimization for improved expression in CHO cells.
Using state-of-the-art imaging devices, Cerbios is able to offer single clone isolation with full documentation support in order to meet the regulatory guidelines.
Clones are selected based on growth properties, expression levels and quality profiles. Cerbios performs process development, including medium screening, in batch or feed batch modes in order to obtain higher production yields accompanied by product quality. The process development is performed using a Design Of Experiments approach.